De Fino, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 1.202
EU - Europa 1.031
AS - Asia 961
SA - Sud America 251
AF - Africa 31
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.484
Nazione #
US - Stati Uniti d'America 1.178
SG - Singapore 473
DE - Germania 370
CN - Cina 240
SE - Svezia 226
BR - Brasile 212
IT - Italia 78
FR - Francia 72
GB - Regno Unito 65
IE - Irlanda 51
VN - Vietnam 50
UA - Ucraina 48
IN - India 44
ID - Indonesia 42
FI - Finlandia 33
RU - Federazione Russa 28
IQ - Iraq 21
BD - Bangladesh 16
AR - Argentina 14
TR - Turchia 14
AT - Austria 11
JP - Giappone 11
PL - Polonia 10
CI - Costa d'Avorio 9
BE - Belgio 8
HK - Hong Kong 8
CA - Canada 6
CL - Cile 6
MA - Marocco 6
MX - Messico 6
NL - Olanda 6
ZA - Sudafrica 6
EC - Ecuador 5
IL - Israele 5
IR - Iran 5
JO - Giordania 5
CO - Colombia 4
KR - Corea 4
NP - Nepal 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ES - Italia 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
HT - Haiti 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
NA - Namibia 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
Totale 3.484
Città #
Chandler 313
Singapore 240
Ashburn 94
Beijing 66
Dublin 51
Los Angeles 38
San Mateo 38
Jakarta 37
New York 37
Wilmington 37
Jacksonville 36
Nürnberg 31
Boston 27
Nanjing 23
Milan 20
Moscow 19
Munich 19
Princeton 19
Ann Arbor 18
Hanoi 18
São Paulo 17
Dallas 15
Ho Chi Minh City 15
Cattolica 14
Frankfurt am Main 14
Helsinki 14
Nanchang 14
Dearborn 13
Norwalk 13
Chicago 12
Hefei 12
Lawrence 12
Houston 11
Shanghai 11
Atlanta 10
Marseille 10
Rio de Janeiro 10
Rome 10
Abidjan 9
Buffalo 9
Bremen 8
Brussels 8
Falls Church 8
Hebei 8
Hong Kong 8
London 8
Nuremberg 8
Woodbridge 8
Baghdad 7
Brooklyn 7
Chennai 7
Mountain View 6
Pune 6
Santa Clara 6
Tokyo 6
Amman 5
Dhaka 5
Düsseldorf 5
Fairfield 5
Izmir 5
Johannesburg 5
Kent 5
Lviv 5
Portsmouth 5
Seattle 5
Vienna 5
Amsterdam 4
Andover 4
Ankara 4
Caxias do Sul 4
Coquimbo 4
Denver 4
Fremont 4
Haiphong 4
Kunming 4
Leawood 4
Mumbai 4
Redwood City 4
Seoul 4
São Gonçalo 4
Tehran 4
Tianjin 4
Turku 4
Warsaw 4
Wroclaw 4
Auckland 3
Augusta 3
Brasília 3
Changchun 3
Changsha 3
Chengdu 3
Curitiba 3
Edinburgh 3
Erbil 3
Fairport 3
Falkenstein 3
Florence 3
Fuzhou 3
Hyderabad 3
Jiaxing 3
Totale 1.711
Nome #
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 238
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 168
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 150
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 143
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 139
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 137
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 130
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 114
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 105
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 105
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 102
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 100
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 99
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 99
A unique case of multiphasic ADEM or what else? 99
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 99
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 96
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 95
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 94
Magnetic resonance imaging pattern recognition in sporadic Inclusion-Body Myositis 91
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis 90
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 88
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 87
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 84
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 82
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 79
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 78
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 78
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 77
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture Analysis 74
Delayed hypersensitivity to dimethyl fumarate: Report of 1 case and literature review 72
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 67
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 66
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis 64
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 53
Totale 3.542
Categoria #
all - tutte 16.216
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.216


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 7 8 4 13 8 31 7
2021/2022321 30 6 4 42 12 13 0 50 18 20 46 80
2022/2023730 97 111 65 121 41 87 29 58 70 10 27 14
2023/2024270 18 74 7 7 10 33 20 9 7 10 29 46
2024/2025576 19 23 51 31 32 34 12 19 84 45 129 97
2025/2026897 236 41 88 163 327 42 0 0 0 0 0 0
Totale 3.542